• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON & CO (FRANKLIN LAKES) BD VACUTAINER® LITHIUM HEPARINN (LH) 75 USP UNITS BCT; TUBES, VIALS, SYSTEMS, SERUM SEPARATORS, BLOOD COLLECTION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON & CO (FRANKLIN LAKES) BD VACUTAINER® LITHIUM HEPARINN (LH) 75 USP UNITS BCT; TUBES, VIALS, SYSTEMS, SERUM SEPARATORS, BLOOD COLLECTION Back to Search Results
Catalog Number 367884
Medical Device Problem Code Premature Separation (4045)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/12/2026
Type of Reportable Event Malfunction
Event or Problem Description
It was reported while using bd vacutainer® lithium heparinn (lh) 75 usp units bct, stopper pop off occurred an unspecified number of times.No adverse impact was reported regarding the patient or user.
 
Additional Manufacturer Narrative
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event or Problem Description
It was reported while using bd vacutainer® lithium heparinn (lh) 75 usp units bct, stopper pop off occurred an unspecified number of times.No adverse impact was reported regarding the patient or user.
 
Additional Manufacturer Narrative
The following fields were updated due to additional information: d9: device available for evaluation: yes.H.3 device eval by manufacturer? yes.D9: returned to manufacturer on: 05-feb-2026.Investigation summary: bd received 5 samples for investigation.The 5 samples were inspected with no issues being identified with the stopper.Furthermore, functional tests were performed on four of the returned samples, and all were within specification limits with no issues observed regarding stopper function.Additionally, 100 retained samples were inspected, with zero visible defects.Functional tests were also conducted on ten retained samples, and all were within specification limits.Based on a review of the device history record for the incident lot, all product specifications and requirements for lot release were met.This complaint has not been confirmed for the indicated failure mode: stopper function.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business team regularly reviews the collected data for the identification of emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD VACUTAINER® LITHIUM HEPARINN (LH) 75 USP UNITS BCT
Common Device Name
TUBES, VIALS, SYSTEMS, SERUM SEPARATORS, BLOOD COLLECTION
Manufacturer (Section D)
BECTON DICKINSON & CO (FRANKLIN LAKES)
1 becton drive
franklin lakes NJ 07417
Manufacturer (Section G)
BECTON, DICKINSON & CO. (BROKEN BOW)
150 south 1st avenue
broken bow NE 68822
Manufacturer Contact
anand singh
1 becton drive
franklin lakes, NJ 07417
2018475186
MDR Report Key24273086
Report Number1917413-2026-00046
Device Sequence Number10722747
Product Code JKA
UDI-Device Identifier30382903678847
UDI-Public(01)30382903678847(17)260630(10)5059119
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
K901449
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 02/26/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date06/30/2026
Device Catalogue Number367884
Device Lot Number5059119
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/12/2026
Supplement Date Received by Manufacturer02/26/2026
Initial Report FDA Received Date02/05/2026
Supplement Report FDA Received Date03/30/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/28/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-